Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-19-006696
Filing Date
2019-05-09
Accepted
2019-05-09 16:39:39
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10ka.htm 10-K/A 315659
2 ex31-3.htm EX-31.3 6137
3 ex31-4.htm EX-31.4 6093
  Complete submission text file 0001493152-19-006696.txt   329229
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36457 | Film No.: 19811243
SIC: 2834 Pharmaceutical Preparations